These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10758614)

  • 21. Determination of medullary thyroid carcinoma metastases by 201Tl, 99Tcm(V)DMSA, 99Tcm-MIBI and 99Tcm-tetrofosmin.
    Adalet I; Koçak M; Ogŭz H; Alagöl F; Cantez S
    Nucl Med Commun; 1999 Apr; 20(4):353-9. PubMed ID: 10319355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel tumortropic ester derivatives of 99mTc(V) mesodimercapto succinic acid with low affinity for bone tissue.
    Seifert S; Syhre R; Spies H; Johannsen B
    Nucl Med Commun; 2003 Nov; 24(11):1175-83. PubMed ID: 14569172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics, biodistribution and dosimetry of 99Tcm(V)DMSA in humans with squamous cell carcinoma.
    Watkinson JC; Allen S; Lazarus CR; Sinclair J; Blake GM; Clarke SE
    Nucl Med Commun; 1990 May; 11(5):343-59. PubMed ID: 2164650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 99Tcm (v) DMSA and 67Ga-citrate imaging in patients with head and neck squamous carcinoma: a clinical and scintigraphic study.
    Watkinson JC; Lazarus CR; Maisey MN; Clarke SE
    Nucl Med Commun; 1990 Feb; 11(2):103-10. PubMed ID: 2162508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (99m)Technetium pentavalent dimercaptosuccinic acid scintigraphy in the follow-up of clinically nonfunctioning pituitary adenomas after radiotherapy.
    Colao A; Ferone D; Lombardi G; Lastoria S
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):713-21. PubMed ID: 12072040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tc-99m MIBI, Tc-99m tetrofosmin, and Tc-99m (V) DMSA accumulation in recurrent malignant thymoma.
    Kim SJ; Kim IJ; Kim YK
    Clin Nucl Med; 2002 Jan; 27(1):30-3. PubMed ID: 11805481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 99mTc-(V) DMSA uptake in systemic AL amyloidosis and normal bone scintigraphy.
    Sonmez B; Cekic AB; Erkut N; Piskin B; Sonmez M
    Hell J Nucl Med; 2010; 13(1):69-70. PubMed ID: 20411178
    [No Abstract]   [Full Text] [Related]  

  • 28. Pentavalent Tc-99m dimercaptosuccinic acid imaging of hepatocellular carcinoma.
    Wang SJ; Lin WY; Wey SP; Shen LH; Ting G
    Neoplasma; 1999; 46(4):246-8. PubMed ID: 10613606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo studies with pentavalent technetium-99m dimercaptosuccinic acid.
    Lam AS; Puncher MR; Blower PJ
    Eur J Nucl Med; 1996 Dec; 23(12):1575-82. PubMed ID: 8929310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of Tc-99m (V) dimercaptosuccinic acid in detecting intra-abdominal infection: compared with gallium scan.
    Lin WY; Hung GU; Chao TH
    Ann Nucl Med; 2007 Jul; 21(5):285-91. PubMed ID: 17634846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 99mTc(V)-DMSA scintigraphy in monitoring the response of bone disease to vitamin D3 therapy in renal osteodystrophy.
    Sarikaya A; Sen S; Hacimahmutoglu S; Pekindil G
    Ann Nucl Med; 2002 Feb; 16(1):19-23. PubMed ID: 11922204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dimercaptosuccinic acid distribution in renal tubular acidosis.
    Green DA; Davies SG
    Br J Radiol; 1997 Dec; 70(840):1291-2. PubMed ID: 9505851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative SPET 99Tcm-DMSA uptake by the kidneys: age-related decline in healthy males.
    Groshar D; Gorenberg M; Osamah H
    Nucl Med Commun; 1998 Sep; 19(9):893-7. PubMed ID: 10581596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diphosphonates in the evaluation of metabolic bone disease.
    Fogelman I; Smith ML
    Clin Rheumatol; 1982 Mar; 1(1):41-4. PubMed ID: 6236012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is the source of the skeletal affinity of 99mTc-V-DMSA?
    Athanasoulis T; Koutsikos J; Zerva C
    Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1673-4; author reply 1675-6. PubMed ID: 15452672
    [No Abstract]   [Full Text] [Related]  

  • 36. Absolute 24 h quantification of 99Tcm-DMSA uptake in patients with severely reduced kidney function: a comparison with 51Cr-EDTA clearance.
    van de Wiele C; van den Eeckhaut A; Verweire W; van Haelst JP; Versijpt J; Dierckx RA
    Nucl Med Commun; 1999 Sep; 20(9):829-32. PubMed ID: 10533188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of stannous oxidation in the preparation of ultrahigh-purity 99m Tc(V)-DMSA.
    Kumar V
    Nucl Med Commun; 2001 Nov; 22(11):1261-6. PubMed ID: 11606894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common bone features in osteomalacia, secondary hyperparathyroidism, and renal osteodystrophy.
    Verlooy H; De Roo M; Mortelmans L; Dequeker J
    Clin Nucl Med; 1991 May; 16(5):372-4. PubMed ID: 2054996
    [No Abstract]   [Full Text] [Related]  

  • 39. Technetium-99m-dimercaptosuccinic acid renal scintigraphy can guide clinical management in congenital hydronephrosis.
    Bazić-Đorović B; Radulović M; Šišić M; Jauković L; Dugonjić S; Pucar D; Janković Z; Beatović S; Janković M; Krstić Z; Ajdinović B
    Hell J Nucl Med; 2017; 20 Suppl():114-122. PubMed ID: 29324920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simple and reliable preparation of pentavalent 99Tcm-dimercaptosuccinic acid at alkaline pH without oxygen bubbling.
    Oh SJ; Ha HJ; Moon DH; Ryu JS; Lee HK
    Nucl Med Commun; 2001 Jun; 22(6):613-6. PubMed ID: 11403170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.